Biomarker Assessments Reveal Global Vitamin B2 Deficiencies in Women and Children

Why It Matters

Riboflavin deficiency undermines iron metabolism, folate pathways and vitamin B6 activation, heightening anemia risk and broader nutritional deficits. Addressing this gap is critical for public‑health nutrition strategies worldwide.

Key Takeaways

• Women show higher riboflavin deficiency than men globally
• Deficiency rates exceed 70% in many low‑income nations
• Riboflavin supports iron metabolism and reduces anemia risk
• EGRac assay provides reliable biomarker for riboflavin status
• Teenagers exhibit rising deficiency, up to 50% in UK

Pulse Analysis

The study underscores a hidden micronutrient crisis: riboflavin deficiency is not confined to resource‑poor settings but is prevalent across income levels, with women and adolescents most vulnerable. By employing the EGRac assay, the researchers offered a robust, comparable metric that overcomes the inconsistencies of dietary surveys alone. This biomarker‑driven approach reveals that traditional intake data may underestimate the true scope of deficiency, prompting a reevaluation of global nutrition monitoring frameworks.

Beyond its role as a cofactor for FMN and FAD, riboflavin directly influences iron homeostasis, folate metabolism, and the activation of vitamin B6. Deficient individuals often experience impaired hemoglobin synthesis, heightened anemia risk, and disrupted one‑carbon metabolism, which can affect fetal development and cognitive function in children. The gender disparity observed—women consuming less riboflavin and exhibiting higher deficiency—amplifies concerns for reproductive health, given riboflavin’s impact on iron mobilization and menstrual blood loss.

Policy implications are immediate. Nations may consider fortifying staple foods such as flour, rice, or dairy with riboflavin, mirroring successful vitamin A and iron programs. The commercial sector can capitalize on this need by expanding riboflavin‑enriched products and targeted supplements for women of child‑bearing age and adolescents. Further research should test the efficacy of such interventions on biomarker outcomes and clinical endpoints, providing the evidence base needed for updated dietary reference intakes and global health guidelines.